{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:09:16Z","timestamp":1789013356230,"version":"build-2803163510"},"reference-count":0,"publisher":"Nepal Health Research Council","issue":"03","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["jnhrc"],"abstract":"<jats:p>Background: This systematic review aimed to determine the antimicrobial resistance pattern of the extended-spectrum ?-lactamases producing Escherichia coli (ESBL-EC) in urine samples in Nepal.Methods: Systematic literature review was conducted to locate all articles reporting ESBL-EC in urine samples published between January 2012 to December 2022. The Egger\u2019s weighted regression analysis was done to assess the publication bias. A random-effects model was used to calculate the pooled prevalence and corresponding 95% confidence interval due to significant between-study heterogeneity. The strength of correlation between multidrug resistance and ESBL production in E.coli strains was determined using Pearson\u2019s correlation coefficient. The data were analyzed using R-language 4.2.2. software.Results: The combined prevalence of E.coli in urine samples was found to be 14 % (95% CI, 11-18), while the overall pooled prevalence of ESBL E.coli and MDR E.coli were 30% (95% CI, 20-42) and 70% (95% CI, 38-90) respectively. A strong positive correlation of 0.99 (95% CI, 0.89-1.0) was found between ESBL production and MDR among E.coli isolates. Imipenem was the drug of choice against ESBL-E.coli in urine specimens.Conclusions: Our analyses showed the overall ESBL-EC and MDR-EC burden in Nepal is considerably high. Likewise, the study also infers an increasing trend of antibiotic resistance pattern of ESBL-EC in urine samples. Keywords: ESBL-E.coli; multi-drug resistance; Nepal; urine.<\/jats:p>","DOI":"10.33314\/jnhrc.v21i3.4723","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T01:28:30Z","timestamp":1732584510000},"page":"353-365","source":"Crossref","is-referenced-by-count":0,"title":["Decadal Analysis of ESBL-Escherichia coli Antibiotic Resistance Patterns in Urine Samples from Nepal: A Systematic Review and Meta-Analysis"],"prefix":"10.33314","volume":"21","author":[{"given":"Bibek Rana","family":"Chhetri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha Raj","family":"Banjara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18778","published-online":{"date-parts":[[2024,3,22]]},"container-title":["Journal of Nepal Health Research Council"],"original-title":[],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:53:42Z","timestamp":1789012422000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnhrc.com.np\/index.php\/jnhrc\/article\/view\/756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":0,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2024,3,22]]}},"URL":"https:\/\/doi.org\/10.33314\/jnhrc.v21i3.4723","relation":{},"ISSN":["1999-6217","1727-5482"],"issn-type":[{"value":"1999-6217","type":"electronic"},{"value":"1727-5482","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,22]]}}}